Gene Therapy for Hemophilia: Are We There Yet?
Oct 31, 2016
Recent gene therapy trial for hemophilia B showed promising results, with patients’ average factor IX level of 32 percent after treatment. CHOP aims to open a hemophilia A gene therapy trial modeled after the hemophilia B trial.